Cell and tissue engineering for liver disease

Author(s)
Zaret, K. S.; Fox, I. J.; Bhatia, Sangeeta N; Underhill, Gregory
Thumbnail
DownloadCell and tissue engineering.pdf (2.243Mb)
OPEN_ACCESS_POLICY
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
Despite the tremendous hurdles presented by the complexity of the liver’s structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation.
Date issued
2016-07
URI
http://hdl.handle.net/1721.1/110764
Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science; Harvard University--MIT Division of Health Sciences and Technology; Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Journal
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Bhatia, S. N., G. H. Underhill, K. S. Zaret, and I. J. Fox. “Cell and Tissue Engineering for Liver Disease.” Science Translational Medicine 6, no. 245 (July 16, 2014): 245sr2–245sr2.
Version: Author's final manuscript
ISSN
1946-6234
1946-6242
Collections